Vireo Health to Report Second Quarter 2019 Results on August 29, 2019

MINNEAPOLIS, Aug. 21, 2019 /PRNewswire/ --Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO;OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that it will report financial results for its second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens.

Metadata
Provider: 
PR Newswire
Retrieved on: 
Wednesday, August 21, 2019
Information
Tags: 
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medicine, Medical specialties, Plants
Geotags: 
Minnesota
Organisation: 
VIREO HEALTH INTERNATIONAL, INC.
Website: 
http://www.vireohealth.com
Summary
Key Points: 
  • MINNEAPOLIS, Aug. 21, 2019 /PRNewswire/ --Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO;OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that it will report financial results for its second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens.
  • The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
  • Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry.
  • Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries.


Vireo Health to Report Second Quarter 2019 Results on August 29, 2019

MINNEAPOLIS, Aug. 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that it will report financial results for its second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens.  

Vireo Logo (PRNewsfoto/Vireo Health, Inc.)

The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). A live audio webcast of the call will be available in the Events & Presentations section of Vireo's website at https://investors.vireohealth.com/events-and-presentations/default.aspx. The conference call may also be accessed by dialing 866-211-3165 (Toll-Free) or 647-689-6580 (International) and entering conference ID 4049456. A webcast replay will be available for one year on Vireo's website.

About Vireo Health International, Inc.

Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo's physician-led team of more than 350 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company is currently licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.

Contact Information            

Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
[email protected]
(612) 314-8995

Media Inquiries
Albe Zakes
Vice President, Corporate Communications
[email protected]   
(267) 221-4800

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/vireo-health-to-report-second-quarter-2019-results-on-august-29-2019-300905117.html

SOURCE Vireo Health International, Inc.

Copyright: 
2019 PR Newswire. All Rights Reserved.